As a sponsor, you can be assured that the Renal Disease Research Institute has the resources you need to conduct quality, groundbreaking kidney disease research. We work hard to play an important role in achieving medical breakthroughs for our sponsors.
Large, Diverse Pool of Patients
RDRI is the research entity that allows Dallas Nephrology Associates to conduct clinical trials that will improve our future ability to treat kidney disease and give our patients the opportunity to receive cutting-edge therapy.
When you award a study to RDRI, you gain access to a large pool of potential participants because we have 90-plus nephrologists who practice at Dallas Nephrology Associate. With locations across the Dallas-Fort Worth Metroplex, our Dallas Nephrology Associates investigators have access to a large pool of patients with a variety of sometimes-rare diseases, giving you the best data to help to accurately perform and recruit for your study.
Medical Excellence and Innovations
Our investigators have years of nephrology experience in both practice and research. Take a look at some of our achievements:
Dallas Nephrology Associates (DNA) physicians successfully completed the 100th EndoAVF procedure at the DNA Vascular Center in Plano on [DATE]. Led by Interventional Nephrologist Neghae Mawla, M.D., the team at the Vascular Center is one of the first in Texas to successfully create these minimally invasive fistulas.
Read More >
Why Choose RDRI For Your Clinical Trial?
Since our founding in 2015, RDRI has worked with sponsors all over the world. Our affiliation with Dallas Nephrology Associates gives us the unique ability to conduct in-clinic and outpatient dialysis studies.
We have a dedicated recruiter and the ability to conduct studies at locations across the Dallas-Fort Worth area.
RDRI has capabilities including eRegulatory and eSOURCE, and the use of a central IRB, and if needed, has access to the local institutional review board as well.
Looking for a Clinical Research Study?
New studies are posted to our website and LinkedIn on a regular basis. Check back frequently for updates.